How many drugs treat Merkel cell carcinoma?

Drug Landscape tracks 5 marketed treatments for Merkel cell carcinoma (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/merkel-cell-carcinoma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Merkel cell carcinoma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Merkel cell carcinoma (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Merkel cell carcinoma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Zynyz	RETIFANLIMAB	Incyte Corp	Programmed Death Receptor-1 Blocking Antibody [EPC]	Programmed cell death protein 1	2023-01-01
Bavencio	avelumab	Merck KGaA	Programmed Death Ligand-1 Blocker [EPC]	Programmed cell death 1 ligand 1	2017-01-01
PF-07220060 + PF-07104091 combination dose escalation	pf-07220060-pf-07104091-combination-dose-escalation	Pfizer	Not specified	Not specified
ZYNYZ	RETIFANLIMAB-DLWR	INCYTE CORP	Programmed Death Receptor-1 Blocking Antibody [EPC]	Programmed cell death protein 1
Bavencio	Bavencio	Pfizer		Programmed cell death 1 ligand 1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 2 drugs in Merkel cell carcinoma
INCYTE CORP · 1 drug in Merkel cell carcinoma
Incyte Corp · 1 drug in Merkel cell carcinoma
Merck KGaA · 1 drug in Merkel cell carcinoma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Merkel cell carcinoma:

Cite this brief

Drug Landscape (2026). Merkel cell carcinoma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/merkel-cell-carcinoma. Accessed 2026-06-10.

Merkel cell carcinoma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing